These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 31437433)

  • 1. Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT
    Galaj E; Bi GH; Yang HJ; Xi ZX
    Neuropharmacology; 2020 May; 167():107740. PubMed ID: 31437433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
    Galaj E; Xi ZX
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
    Bi GH; Galaj E; He Y; Xi ZX
    Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xie2-64, a novel CB
    Jordan CJ; Feng ZW; Galaj E; Bi GH; Xue Y; Liang Y; McGuire T; Xie XQ; Xi ZX
    Neuropharmacology; 2020 Oct; 176():108241. PubMed ID: 32712273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Yang Z; Li SJ; Li X; Dillon C; Peng XQ; Spiller K; Gardner EL
    Neuropharmacology; 2007 Nov; 53(6):771-82. PubMed ID: 17888459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
    Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
    Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
    Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats.
    Xi ZX; Kiyatkin M; Li X; Peng XQ; Wiggins A; Spiller K; Li J; Gardner EL
    Neuropharmacology; 2010 Jan; 58(1):304-13. PubMed ID: 19559037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
    Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
    Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.
    Chaves YC; Genaro K; Crippa JA; da Cunha JM; Zanoveli JM
    Metab Brain Dis; 2021 Apr; 36(4):639-652. PubMed ID: 33464458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
    Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptor 7 modulates the rewarding effects of cocaine in rats: involvement of a ventral pallidal GABAergic mechanism.
    Li X; Li J; Peng XQ; Spiller K; Gardner EL; Xi ZX
    Neuropsychopharmacology; 2009 Jun; 34(7):1783-96. PubMed ID: 19158667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens.
    Xi ZX; Gilbert JG; Peng XQ; Pak AC; Li X; Gardner EL
    J Neurosci; 2006 Aug; 26(33):8531-6. PubMed ID: 16914679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol reduces ethanol consumption, motivation and relapse in mice.
    Viudez-Martínez A; García-Gutiérrez MS; Navarrón CM; Morales-Calero MI; Navarrete F; Torres-Suárez AI; Manzanares J
    Addict Biol; 2018 Jan; 23(1):154-164. PubMed ID: 28194850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB
    Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
    Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism.
    Li X; Peng XQ; Jordan CJ; Li J; Bi GH; He Y; Yang HJ; Zhang HY; Gardner EL; Xi ZX
    Sci Rep; 2018 Feb; 8(1):3686. PubMed ID: 29487381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments.
    Mori MA; Meyer E; da Silva FF; Milani H; Guimarães FS; Oliveira RMW
    Eur J Neurosci; 2021 Mar; 53(6):1738-1751. PubMed ID: 33522084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors.
    Rodrigues da Silva N; Gomes FV; Sonego AB; Silva NRD; Guimarães FS
    Pharmacol Res; 2020 Jun; 156():104749. PubMed ID: 32151683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.